Clinical Validation of the Blood Pressure Measuring Device Withings BPM Pro 2 (WIHYP-GP)
WIHYP-GP
Clinical Validation Of The Brachial Blood Pressure Measuring Device Withings BPM Pro 2 According To "The Universal Protocol For The Validation Of Blood Pressure Measuring Devices By The Association For The Advancement Of Medical Instrumentation / European Society Of Hypertension / International Organization For Standardization (AAMI/ESH/ISO) (And Its Amendment 1 (2020) And 2 (2024))" In The General Population.
1 other identifier
interventional
89
1 country
1
Brief Summary
The aim of the study is to assess the accuracy of the automatic oscillometric BP measuring device at the brachial level, the WITHINGS BPM Pro 2, in the general population
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable hypertension
Started Apr 2025
Shorter than P25 for not_applicable hypertension
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 28, 2025
CompletedFirst Submitted
Initial submission to the registry
May 2, 2025
CompletedFirst Posted
Study publicly available on registry
May 5, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 21, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
November 18, 2025
CompletedFebruary 18, 2026
February 1, 2026
4 months
May 2, 2025
February 17, 2026
Conditions
Outcome Measures
Primary Outcomes (2)
Blood pressure measurement performance evaluation per measure
The blood pressure (systolic and diastolic blood pressure) measurement performance will be established using the mean value of the differences and the standard deviation between the device under study and the reference for each measure.
The time frame is three months.
Blood pressure measurement performance evaluation by subject
The blood pressure measurement performance by subject will be established using the mean value of the differences and the standard deviation between the averaged per subject value of blood pressure (systolic and diastolic blood pressure) device under study and its reference.
The time frame is three months.
Secondary Outcomes (1)
Safety use of the device
The time frame is three months.
Study Arms (1)
All patients
EXPERIMENTALPatients consenting to participate to the study and compliant to the inclusion criteria
Interventions
The patient will be measured alternatively with a reference mercury sphygmomanometer (four times) and the device under study (3 times)
Eligibility Criteria
You may qualify if:
- Patient older than 18 years;
- Patient who signed the informed consent form;
- Patient followed-up at site (in-patient or out-patient);
- Patient with arm circumference between 22 cm and 42 cm.
You may not qualify if:
- Patient unable to give a consent or understand properly protocol information;
- Patient suffering from arrhythmia;
- Patient with poor quality of Korotkov sounds;
- Patient for whom K5 sounds are absent;
- Patient wearing an implantable electric medical device (pacemaker,…);
- Patient with both upper arms suffering from open wound and/or damaged skin.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Withingslead
Study Sites (1)
N2
Yerevan, 0002, Armenia
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DEVICE FEASIBILITY
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 2, 2025
First Posted
May 5, 2025
Study Start
April 28, 2025
Primary Completion
August 21, 2025
Study Completion
November 18, 2025
Last Updated
February 18, 2026
Record last verified: 2026-02
Data Sharing
- IPD Sharing
- Will not share